1
TITLE: S-acylation and neuroinflammation: the therapeutic potential of zDHHC and deacylase modulation  Full Text
AUTHORS: Duarte, Tiago A.; Ng, Choa P.; Salvador, Jorge A. R.; Pipito, Ludovico; Greaves, Jennifer; Moreira, Vania M.;
PUBLISHED: 2026, SOURCE: EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, VOLUME: 303
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
2
TITLE: 32nd Annual GP2A Medicinal Chemistry Conference
AUTHORS: Jean-Jacques Hélesbeux; Florence O McCarthy; Maria Manuel Silva; Alcino J Leitão; Anthony Burke; Jorge A R Salvador; Rui Moreira ; Emília Sousa ; Vânia M Moreira; Pascal Marchand;
PUBLISHED: 2025, SOURCE: Drugs and Drug Candidates, VOLUME: 4, ISSUE: 1
INDEXED IN: CrossRef
IN MY: ORCID
3
TITLE: Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs
AUTHORS: Vicente, Andre T. S.; Moura, Sara P. S. P.; Salvador, Jorge A. R.;
PUBLISHED: 2025, SOURCE: COMMUNICATIONS CHEMISTRY, VOLUME: 8, ISSUE: 1
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
4
TITLE: Synthesis and biological evaluation of novel carnosic acid derivatives with anticancer activity
AUTHORS: Moura, Sara P. S. P.; Cascante, Marta; Rufino, Ismael; Guedes, Rita C.; Marin, Silvia; Salvador, Jorge A. R.;
PUBLISHED: 2025, SOURCE: RSC ADVANCES, VOLUME: 15, ISSUE: 44
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
5
TITLE: Deep learning for small-molecule drug discovery: From molecular design to clinical translation
AUTHORS: Rita I Oliveira; Tiago O Pereira; Maryam Abbasi; Jorge A.R Salvador; Joel P Arrais;
PUBLISHED: 2025, SOURCE: Journal of Pharmaceutical Analysis
INDEXED IN: CrossRef
IN MY: ORCID
6
TITLE: Abstract 3165: Leveraging chemoinformatics and high-throughput screening for the identification of novel ubiquitin specific protease 7 (USP7) inhibitors
AUTHORS: Rita I Oliveira; Caio Franco; Miguel Mano; Ana Leal; Karen T Liby; Jorge A R Salvador;
PUBLISHED: 2025, SOURCE: Cancer Research, VOLUME: 85, ISSUE: 8_Supplement_1
INDEXED IN: CrossRef
IN MY: ORCID
7
TITLE: Decoding the secrets: how conformational and structural regulators inhibit the human 20S proteasome
AUTHORS: Fernandes, Pedro M. P.; Guedes, Romina A.; Victor, Bruno L.; Salvador, Jorge A. R.; Guedes, Rita C.;
PUBLISHED: 2024, SOURCE: FRONTIERS IN CHEMISTRY, VOLUME: 11
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
8
TITLE: Bioactive Bismuth Compounds: Is Their Toxicity a Barrier to Therapeutic Use?
AUTHORS: Ângela Gonçalves; Mariana Matias; Jorge R Salvador; Samuel Silvestre;
PUBLISHED: 2024, SOURCE: International Journal of Molecular Sciences, VOLUME: 25, ISSUE: 3
INDEXED IN: Scopus CrossRef: 2
IN MY: ORCID
9
TITLE: PROteolysis-Targeting Chimeras (PROTACs) in leukemia: overview and future perspectives
AUTHORS: Vicente, Andre T. S.; Salvador, Jorge A. R.;
PUBLISHED: 2024, SOURCE: MEDCOMM, VOLUME: 5, ISSUE: 6
INDEXED IN: Scopus WOS CrossRef
IN MY: ORCID
10
Page 1 of 10. Total results: 92.